FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045362572> ?p ?o ?g. }

• W2045362572 abstract "Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FLBreast cancer is the commonest type of cancer among women in the US and the second leading cancer-death cause. Understanding its biology will help to design new clinical approaches to achieve a better outcome of the disease. microRNA (miRNA) are short ribonucleic acids with important regulatory functions and with an increasingly acknowledged role in cancer. The present study was designed to characterize progestin-induced miRNA regulation in breast cancer. Primary cultures of the murine breast cancer C4HD were treated or not with 10nM of the synthetic progestin medroxiprogesterone acetate (MPA) for 24 h and total RNA extracted for miRNA profiling using Applied Biosystems low density qPCR arrays. Analysis of data rendered a total of 16 miRNA significantly regulated (P<0.05): miR-378*, miR-376a, miR-224, miR-190b, miR-16, miR-410 and miR-197 were downregulated and miR-191*, miR-17*, miR-470*, miR-451, miR-702, miR-434-3p, miR-493, miR-23a* and miR-485* were upregulated under treatment with MPA. Interestingly, miR-16 has already been shown to be a tumor suppressor in leukemia and so we focused our further study on it. We validated the downregulation of miR-16 by qPCR (0.4 fold against control) and observed that small interference RNA (siRNA) to progesterone receptor (PR) or to signal transducer and activator of signal 3 (STAT3) overcame miR-16 downregulation by MPA. The oncogene c-Myc was a reported negative regulator of miR-16, and we observed that siRNA to PR or STAT3 inhibited MPA-induced c-Myc upregulation. A query for miR-16 targets on miRecords search engine showed that the cell cycle promoter gene Cyclin E has conserved putative target sites on 3′UTR mRNA. Consistently, siRNA to PR and to STAT3 inhibited MPA-induced CCNE mRNA and Cyclin E protein increase as assessed by qPCR and Western blot. In addition, transfection with pre-miR-16 abrogated MPA capacity of inducing Cyclin E upregulation. Most importantly, pre-miR-16 inhibited MPA-induced proliferation, as observed in [3H]-Thymidine incorporation assays and Trypan-blue cell counts. C4HD is a progestin-dependent tumor since it is unable to grow in vivo under exogenous progestin's absence. Therefore, 1 × 106 C4HD cells transfected with a pre-miR-control (CTRL) or with pre-miR-16 were injected s.c. in 8-week female Balb/c mice which had been previously injected with a MPA slow-release depot. Tumors became palpable at day 15 but the ones from pre-miR-16 group grew at a lower rate than the ones from pre-miR-CTRL group, and the mean tumor volume at day 40 was significantly smaller (312.4 ± 42.3 mm3 for CTRL group against 22.2 ± 34.9 mm3 for pre-miR-16 group). To sum up, these results suggest that progestin induce breast cancer growth through a pathway involving PR/STAT3/c-Myc and miR-16 which acts on mRNA targets such as Cyclin E to control cell cycle progression.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 3982. doi:10.1158/1538-7445.AM2011-3982" @default.
• W2045362572 created "2016-06-24" @default.
• W2045362572 creator A5003805715 @default.
• W2045362572 creator A5003931922 @default.
• W2045362572 creator A5022119745 @default.
• W2045362572 creator A5060510549 @default.
• W2045362572 creator A5073909973 @default.
• W2045362572 date "2011-04-15" @default.
• W2045362572 modified "2023-09-26" @default.
• W2045362572 title "Abstract 3982: Deregulation of tumor-suppressive miR-16 through progestin-mediated oncogenic signaling contributes to breast cancer development" @default.
• W2045362572 doi "https://doi.org/10.1158/1538-7445.am2011-3982" @default.
• W2045362572 hasPublicationYear "2011" @default.
• W2045362572 type Work @default.
• W2045362572 sameAs 2045362572 @default.
• W2045362572 citedByCount "0" @default.
• W2045362572 crossrefType "proceedings-article" @default.
• W2045362572 hasAuthorship W2045362572A5003805715 @default.
• W2045362572 hasAuthorship W2045362572A5003931922 @default.
• W2045362572 hasAuthorship W2045362572A5022119745 @default.
• W2045362572 hasAuthorship W2045362572A5060510549 @default.
• W2045362572 hasAuthorship W2045362572A5073909973 @default.
• W2045362572 hasConcept C104317684 @default.
• W2045362572 hasConcept C121608353 @default.
• W2045362572 hasConcept C126322002 @default.
• W2045362572 hasConcept C127561419 @default.
• W2045362572 hasConcept C143998085 @default.
• W2045362572 hasConcept C145059251 @default.
• W2045362572 hasConcept C166703698 @default.
• W2045362572 hasConcept C2781018059 @default.
• W2045362572 hasConcept C29537977 @default.
• W2045362572 hasConcept C502942594 @default.
• W2045362572 hasConcept C530470458 @default.
• W2045362572 hasConcept C54355233 @default.
• W2045362572 hasConcept C67705224 @default.
• W2045362572 hasConcept C71924100 @default.
• W2045362572 hasConcept C86803240 @default.
• W2045362572 hasConceptScore W2045362572C104317684 @default.
• W2045362572 hasConceptScore W2045362572C121608353 @default.
• W2045362572 hasConceptScore W2045362572C126322002 @default.
• W2045362572 hasConceptScore W2045362572C127561419 @default.
• W2045362572 hasConceptScore W2045362572C143998085 @default.
• W2045362572 hasConceptScore W2045362572C145059251 @default.
• W2045362572 hasConceptScore W2045362572C166703698 @default.
• W2045362572 hasConceptScore W2045362572C2781018059 @default.
• W2045362572 hasConceptScore W2045362572C29537977 @default.
• W2045362572 hasConceptScore W2045362572C502942594 @default.
• W2045362572 hasConceptScore W2045362572C530470458 @default.
• W2045362572 hasConceptScore W2045362572C54355233 @default.
• W2045362572 hasConceptScore W2045362572C67705224 @default.
• W2045362572 hasConceptScore W2045362572C71924100 @default.
• W2045362572 hasConceptScore W2045362572C86803240 @default.
• W2045362572 hasLocation W20453625721 @default.
• W2045362572 hasOpenAccess W2045362572 @default.
• W2045362572 hasPrimaryLocation W20453625721 @default.
• W2045362572 hasRelatedWork W1497618943 @default.
• W2045362572 hasRelatedWork W2321699665 @default.
• W2045362572 hasRelatedWork W2323324457 @default.
• W2045362572 hasRelatedWork W2351075837 @default.
• W2045362572 hasRelatedWork W2558823012 @default.
• W2045362572 hasRelatedWork W2564321365 @default.
• W2045362572 hasRelatedWork W2573560023 @default.
• W2045362572 hasRelatedWork W2886622015 @default.
• W2045362572 hasRelatedWork W2950300170 @default.
• W2045362572 hasRelatedWork W2961261137 @default.
• W2045362572 hasRelatedWork W2979986004 @default.
• W2045362572 hasRelatedWork W2996768385 @default.
• W2045362572 hasRelatedWork W3000160552 @default.
• W2045362572 hasRelatedWork W3029330018 @default.
• W2045362572 hasRelatedWork W3030096132 @default.
• W2045362572 hasRelatedWork W3031661890 @default.
• W2045362572 hasRelatedWork W3089771442 @default.
• W2045362572 hasRelatedWork W3135468641 @default.
• W2045362572 hasRelatedWork W3142666815 @default.
• W2045362572 hasRelatedWork W3143486913 @default.
• W2045362572 isParatext "false" @default.
• W2045362572 isRetracted "false" @default.
• W2045362572 magId "2045362572" @default.
• W2045362572 workType "article" @default.